URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

Peter M. Neupert net worth and biography

Peter Neupert Biography and Net Worth

Director of Fortrea

Peter Neupert is chair of the Nominating, Corporate Governance and Compliance Committee and serves as a member of the Audit Committee. Mr. Neupert served as an Operating Partner at Health Evolution Partners, a private equity fund, from February 2012 to July 2014. Prior to joining Health Evolution Partners, Mr. Neupert served as Corporate Vice President, Health Solutions Group at Microsoft from August 2005 to January 2012, and as the Chief Executive Officer and Chairman of the board of directors of Drugstore.com, which he joined in July 1998. Since 2013, Mr. Neupert has served as a director of Labcorp and as a director of Adaptive Biotechnologies Corporation. Mr. Neupert previously served as a member of the board of directors of NextGen Healthcare, Inc., a public software company, and several private companies. Mr. Neupert served as a member of the Board of Trustees of Fred Hutchinson Cancer Research Center from June 2007 to June 2020. Mr. Neupert holds an MBA from the Tuck School of Business at Dartmouth College and a BA in Philosophy from Colorado College. Mr. Neupert was selected to serve on our board of directors because of his extensive knowledge and experience in the field of healthcare information technology and his experience as a director and executive officer of several public companies.

What is Peter M. Neupert's net worth?: The estimated net worth of Peter M. Neupert is at least $423,642.96 as of August 23rd, 2023. Mr. Neupert owns 21,996 shares of Fortrea stock worth more than $423,643 as of December 21st. This net worth estimate does not reflect any other investments that Mr. Neupert may own. Learn More about Peter M. Neupert's net worth.
How do I contact Peter M. Neupert?: The corporate mailing address for Mr. Neupert and other Fortrea executives is 8 Moore Drive, Durham, NC 27709, United States, . Fortrea can also be reached via phone at 877-495-0816 and via email at [email protected]. Learn More on Peter M. Neupert's contact information.
Has Peter M. Neupert been buying or selling shares of Fortrea?: Peter M. Neupert has not been actively trading shares of Fortrea within the last three months. Most recently, on Wednesday, August 23rd, Peter M. Neupert bought 11,000 shares of Fortrea stock. The stock was acquired at an average cost of $25.30 per share, with a total value of $278,300.00. Following the completion of the transaction, the director now directly owns 21,996 shares of the company's stock, valued at $556,498.80. Learn More on Peter M. Neupert's trading history.
Who are Fortrea's active insiders?: Fortrea's insider roster includes Peter Neupert (Director), and Thomas Pike (CEO & Chairman). Learn More on Fortrea's active insiders.
Are insiders buying or selling shares of Fortrea?: In the last twelve months, Fortrea insiders bought shares 2 times. They purchased a total of 12,000 shares worth more than $298,700.00. The most recent insider tranaction occured on June, 12th when General Counsel James S Hanson bought 2,000 shares worth more than $50,600.00. Insiders at Fortrea own 0.1% of the company. Learn More about insider trades at Fortrea.
Information on this page was last updated on 6/12/2024.

Peter M. Neupert Insider Trading History at Fortrea

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/23/2023	Buy	11,000	$25.30	$278,300.00	21,996

Peter M. Neupert Buying and Selling Activity at Fortrea

Fortrea Company Overview

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Today's Range

Now: $19.26

$18.35

$19.53

50 Day Range

MA: $19.70

$16.82

$23.73

2 Week Range

Now: $19.26

$16.53

$41.02

Volume

2,653,824 shs

Average Volume

1,292,983 shs

Market Capitalization

$1.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

>> Register for the Workshop Now